Cost Profile and Budget Implications of Rechargeable Versus Non-rechargeable Sacral Neuromodulation Devices for Neurogenic Lower Urinary Tract Dysfunction

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorQilu Hospital of Shandong University

About this trial

Traditional sacral neuromodulation devices are not rechargeable. In recent years, new rechargeable sacral neuromodulation devices have been developed and put into the market. The aim of this study was to evaluate the cost savings of a rechargeable sacral neuromodulation device versus a non-rechargeable sacral neuromodulation device for the treatment of neurogenic lower urinary tract dysfunction.

Eligibility criteria

Qualifiers

male and female patients with neurogenic lower urinary tract dysfunction who had failed conventional treatment

obstructive urinary retention and contraindications to SNM

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

268 Participants
are grouped into 2 trial groups

Sponsors and collaborators

Qilu Hospital of Shandong University

Lead sponsor

Aerospace Center Hospital

Collaborator

Shandong Provincial Hospital

Collaborator

Second Affiliated Hospital of Xi'an Jiaotong University

Collaborator

Beijing Hospital

Collaborator

Xi'an Honghui Hospital

Collaborator

The First Affiliated Hospital of Zhengzhou University

Collaborator

Second Hospital of Jilin University

Collaborator

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Collaborator

Tongji Hospital

Collaborator